BTK blocks the inhibitory effects of MDM2 on p53 activity.
Rada M, Althubiti M, Ekpenyong-Akiba AE, Lee KG, Lam KP, Fedorova O, Barlev NA, Macip S.
Rada M, et al. Among authors: macip s.
Oncotarget. 2017 Nov 20;8(63):106639-106647. doi: 10.18632/oncotarget.22543. eCollection 2017 Dec 5.
Oncotarget. 2017.
PMID: 29290977
Free PMC article.